Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

PURE Biosciences Inc (OTCQB:PURE)

Delayed Data
As of Feb 08
 +0.04 / +3.45%
Today’s Change
Today|||52-Week Range
Health Technology
Medical Specialties

Company Description

PURE Bioscience, Inc. is engaged in the discovery, development and commercialization of bioscience products that provide solutions to global health challenges. Its technology platform is based on stabilized ionic silver and its products contain Silver Dihydrogen Citrate (SDC). The SDC is a broad-spectrum, non-toxic antimicrobial agent, which is manufactured as a liquid and delivered in various concentrations. The company also manufacture and sell SDC-based formulations to manufacturers for use as a raw material ingredient in the production of personal care products. PURE Bioscience as founded by Michael L. Krall on August 24, 1992 and is headquartered in El Cajon, CA.

Contact Information

PURE Bioscience, Inc.
1725 Gillespie Way
El Cajon California 92020-1098
P:(619) 596-8600
Investor Relations:



Individual stakeholders13.34%
Mutual fund holders0.79%
Other institutional0.38%

Top Executives

Henry R. LambertChief Executive Officer & Director
Mark S. ElliottVP, Chief Financial & Accounting Officer
Bridget TinsleyVice President-Market Development
Tom MyersExecutive VP-Marketing & Product Development
Cliff WechslerExecutive Vice President-Sales